171 related articles for article (PubMed ID: 36260264)
1. Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age.
Cummings SR; Kritchevsky SB
Geroscience; 2022 Dec; 44(6):2925-2931. PubMed ID: 36260264
[TBL] [Abstract][Full Text] [Related]
2. Development of Clinical Trials to Extend Healthy Lifespan.
Justice JN; Niedernhofer L; Robbins PD; Aroda VR; Espeland MA; Kritchevsky SB; Kuchel GA; Barzilai N
Cardiovasc Endocrinol Metab; 2018 Dec; 7(4):80-83. PubMed ID: 30906924
[TBL] [Abstract][Full Text] [Related]
3. A toolkit for quantification of biological age from blood chemistry and organ function test data: BioAge.
Kwon D; Belsky DW
Geroscience; 2021 Dec; 43(6):2795-2808. PubMed ID: 34725754
[TBL] [Abstract][Full Text] [Related]
4. Geroscience and pathology: a new frontier in understanding age-related diseases.
Fekete M; Major D; Feher A; Fazekas-Pongor V; Lehoczki A
Pathol Oncol Res; 2024; 30():1611623. PubMed ID: 38463143
[TBL] [Abstract][Full Text] [Related]
5. Geroscience and Alzheimer's Disease Drug Development.
Cummings J; Leisgang Osse AM; Kinney J
J Prev Alzheimers Dis; 2023; 10(4):620-632. PubMed ID: 37874083
[TBL] [Abstract][Full Text] [Related]
6. New Directions in Geroscience: Integrating Social and Behavioral Drivers of Biological Aging.
Nielsen L; Marsland AL; Hamlat EJ; Epel ES
Psychosom Med; 2024 Jun; 86(5):360-365. PubMed ID: 38718171
[TBL] [Abstract][Full Text] [Related]
7. Challenges in developing Geroscience trials.
Rolland Y; Sierra F; Ferrucci L; Barzilai N; De Cabo R; Mannick J; Oliva A; Evans W; Angioni D; De Souto Barreto P; Raffin J; Vellas B; Kirkland JL;
Nat Commun; 2023 Aug; 14(1):5038. PubMed ID: 37598227
[TBL] [Abstract][Full Text] [Related]
8. A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup.
Justice JN; Ferrucci L; Newman AB; Aroda VR; Bahnson JL; Divers J; Espeland MA; Marcovina S; Pollak MN; Kritchevsky SB; Barzilai N; Kuchel GA
Geroscience; 2018 Dec; 40(5-6):419-436. PubMed ID: 30151729
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Gerobiotics: probiotics targeting fundamental aging processes.
Tsai YC; Cheng LH; Liu YW; Jeng OJ; Lee YK
Biosci Microbiota Food Health; 2021; 40(1):1-11. PubMed ID: 33520563
[TBL] [Abstract][Full Text] [Related]
11. Revisiting the Hallmarks of Aging to Identify Markers of Biological Age.
Guerville F; De Souto Barreto P; Ader I; Andrieu S; Casteilla L; Dray C; Fazilleau N; Guyonnet S; Langin D; Liblau R; Parini A; Valet P; Vergnolle N; Rolland Y; Vellas B
J Prev Alzheimers Dis; 2020; 7(1):56-64. PubMed ID: 32010927
[TBL] [Abstract][Full Text] [Related]
12. Does Modulation of an Epigenetic Clock Define a Geroprotector?
Schork NJ; Beaulieu-Jones B; Liang W; Smalley S; Goetz LH
Adv Geriatr Med Res; 2022; 4(1):. PubMed ID: 35466328
[TBL] [Abstract][Full Text] [Related]
13. Geroscience-guided repurposing of FDA-approved drugs to target aging: A proposed process and prioritization.
Kulkarni AS; Aleksic S; Berger DM; Sierra F; Kuchel GA; Barzilai N
Aging Cell; 2022 Apr; 21(4):e13596. PubMed ID: 35343051
[TBL] [Abstract][Full Text] [Related]
14. Behavioral and Social Research to Accelerate the Geroscience Translation Agenda.
Moffitt TE
Ageing Res Rev; 2020 Nov; 63():101146. PubMed ID: 32814128
[TBL] [Abstract][Full Text] [Related]
15. Moving geroscience from the bench to clinical care and health policy.
Sierra F; Caspi A; Fortinsky RH; Haynes L; Lithgow GJ; Moffitt TE; Olshansky SJ; Perry D; Verdin E; Kuchel GA
J Am Geriatr Soc; 2021 Sep; 69(9):2455-2463. PubMed ID: 34145908
[TBL] [Abstract][Full Text] [Related]
16. The role of quality of life data as an endpoint for collecting real-world evidence within geroscience clinical trials.
Harinath G; Zalzala S; Nyquist A; Wouters M; Isman A; Moel M; Verdin E; Kaeberlein M; Kennedy B; Bischof E
Ageing Res Rev; 2024 Jun; 97():102293. PubMed ID: 38574864
[TBL] [Abstract][Full Text] [Related]
17. Frameworks for Proof-of-Concept Clinical Trials of Interventions That Target Fundamental Aging Processes.
Justice J; Miller JD; Newman JC; Hashmi SK; Halter J; Austad SN; Barzilai N; Kirkland JL
J Gerontol A Biol Sci Med Sci; 2016 Nov; 71(11):1415-1423. PubMed ID: 27535966
[TBL] [Abstract][Full Text] [Related]
18. Geroscience: Aging and Oral Health Research.
Weintraub JA; Kaeberlein M; Perissinotto C; Atchison KA; Chen X; D'Souza RN; Feine JS; Ghezzi EM; Kirkwood KL; Ryder M; Slashcheva LD; Touger-Decker R; Wu B; Kapila Y
Adv Dent Res; 2023 Nov; 31(1):2-15. PubMed ID: 37933846
[TBL] [Abstract][Full Text] [Related]
19. Surrogate endpoints: a key concept in clinical epidemiology.
Christensen R; Ciani O; Manyara AM; Taylor RS
J Clin Epidemiol; 2024 Mar; 167():111242. PubMed ID: 38142762
[TBL] [Abstract][Full Text] [Related]
20. Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop.
De Gruttola VG; Clax P; DeMets DL; Downing GJ; Ellenberg SS; Friedman L; Gail MH; Prentice R; Wittes J; Zeger SL
Control Clin Trials; 2001 Oct; 22(5):485-502. PubMed ID: 11578783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
